Role of Dual Inhibition of Ang-2 and VEGF-A in Patients with Macular Edema Due to Branch or Central/Hemiretinal Retinal Vein Occlusion: Rationale and Design of the Faricimab▼ Phase 3 BALATON and COMINO Trials
This presentation describes the study design of two identical, global, multicenter, randomized, double-masked, active comparator-controlled phase 3 studies of anti-VEGF treatment-naïve patients with retinal vein occlusion (RVO). The BALATON study enrolls patients with branch RVO and the COMINO study enrolls patients with central/hemiretinal RVO.